Unique ID issued by UMIN | UMIN000012754 |
---|---|
Receipt number | R000014137 |
Scientific Title | Clinical trial of chronically implanted retinal prosthesis by Suprachoroidal-Transretinal Stimulaiton in patient with retinitis pigmentosa |
Date of disclosure of the study information | 2014/01/04 |
Last modified on | 2018/07/10 14:23:41 |
Clinical trial of chronically implanted retinal prosthesis by Suprachoroidal-Transretinal Stimulaiton in patient with retinitis pigmentosa
Clinical trial of chronically implanted retinal prosthesis by Suprachoroidal-Transretinal Stimulaiton
Clinical trial of chronically implanted retinal prosthesis by Suprachoroidal-Transretinal Stimulaiton in patient with retinitis pigmentosa
Clinical trial of chronically implanted retinal prosthesis by Suprachoroidal-Transretinal Stimulaiton
Japan |
retinitis pigmentosa
Ophthalmology |
Others
NO
To investigate safety and efficacy for STS retinal prostheis, we will implant the retinal prostheis to retinitis pigmentosa patients.
Safety,Efficacy
Efficacy; comparison of the results of localization test, motion test, grating acuity, and mobility test.
Safety; slit lamp examination, funduscopy and device check
Efficacy; mobility test, questionnaire for quality of vision, PET, and NIRS
Safety; fluorescein angiography, eye-movement test, OCT,and phosphene test in transcorneal-stimulation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Implantation of retinal prosthesis
40 | years-old | <= |
75 | years-old | >= |
Male and Female
1. Patients who are diagnosed retinitis pigmentosa by multiple ophthalmologists.
2. Patients whose visual acuity are hand motion, light perception, or no light perception.
3. Patients who do not have any severe disease except from eye diseases.
4. Patients who are able to live independent daily life and walk using a white cane.
5. Patients who can go to the hospital for regular examinations after the surgery.
6. Patient's family members are able to take care of their daily living.
7. The age limits are from 40 to 75 years old.
8. Written informed consent is obtained from the patient.
1. Patients with glaucoma, optic nerve disease, or retinal disease except from retinitis pigmentosa.
2. Patients with intracranial disease such as cerebral infarction or brain tumor.
3. Patients who are implanted any electrical device such as a cochlear implant or a deep brain stimulation.
4. Patients who are pregnant.
5. Patients with epilepsy.
6. Patients who cannot find phosphenes by electrical stimulation through cornea with less than 1.5 mA
7. Patients who refuse to receive treatment.
8. Patients who are decided by physicians in charge as being inappropriate this clinical trial.
3
1st name | |
Middle name | |
Last name | Takashi Fujikado |
Osaka University Graduate School of Medicine
Department of Applied Visual Science
2-2 Yamadaoka, Suita, Osaka-pref.
06-6879-3941
fujikado@ophthal.med.osaka-u.ac.jp
1st name | |
Middle name | |
Last name | Takashi Fujikado |
Osaka University Graduate School of Medicine
Department of Applied Visual Science
2-2 Yamadaoka, Suita, Osaka-pref.
06-6879-3941
fujikado@ophthal.med.osaka-u.ac.jp
Department of Applied Visual Science, Osaka University Graduate School of Medicine
Grant-in-Aid for Scientific Research (KAKENHI)
Japanese Governmental office
NO
2014 | Year | 01 | Month | 04 | Day |
Published
Completed
2013 | Year | 09 | Month | 01 | Day |
2013 | Year | 09 | Month | 12 | Day |
2018 | Year | 07 | Month | 10 | Day |
2018 | Year | 07 | Month | 10 | Day |
2014 | Year | 01 | Month | 04 | Day |
2018 | Year | 07 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014137